Nevagi RJ - Search Results

1

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4⁺ T-cell-dependent strain-transcending protective immunity in rodent models.

Okoth WA, Ho M-F, Zaman M, Cooper E, Som P, Burgess M, Walton M, Nevagi RJ, Beattie L, Murphy D, Stanisic DI, Good MF. Okoth WA, et al. Among authors: nevagi rj. mBio. 2023 Nov 14;14(6):e0254723. doi: 10.1128/mbio.02547-23. Online ahead of print. mBio. 2023. PMID: 37962347 Free PMC article.

2

Plasmodium infection and drug cure for malaria vaccine development.

Nevagi RJ, Good MF, Stanisic DI. Nevagi RJ, et al. Expert Rev Vaccines. 2021 Feb;20(2):163-183. doi: 10.1080/14760584.2021.1874923. Epub 2021 Feb 23. Expert Rev Vaccines. 2021. PMID: 33428505 Review.

3

Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines.

Skwarczynski M, Zhao G, Boer JC, Ozberk V, Azuar A, Cruz JG, Giddam AK, Khalil ZG, Pandey M, Shibu MA, Hussein WM, Nevagi RJ, Batzloff MR, Wells JW, Capon RJ, Plebanski M, Good MF, Toth I. Skwarczynski M, et al. Among authors: nevagi rj. Sci Adv. 2020 Jan 29;6(5):eaax2285. doi: 10.1126/sciadv.aax2285. eCollection 2020 Jan. Sci Adv. 2020. PMID: 32064333 Free PMC article.

4

Lipopeptide-Based Oral Vaccine Against Hookworm Infection.

Bartlett S, Eichenberger RM, Nevagi RJ, Ghaffar KA, Marasini N, Dai Y, Loukas A, Toth I, Skwarczynski M. Bartlett S, et al. Among authors: nevagi rj. J Infect Dis. 2020 Mar 2;221(6):934-942. doi: 10.1093/infdis/jiz528. J Infect Dis. 2020. PMID: 31621864

5

Cholic Acid-based Delivery System for Vaccine Candidates against Group A Streptococcus.

Azuar A, Zhao L, Hei TT, Nevagi RJ, Bartlett S, Hussein WM, Khalil ZG, Capon RJ, Toth I, Skwarczynski M. Azuar A, et al. Among authors: nevagi rj. ACS Med Chem Lett. 2019 Jul 24;10(9):1253-1259. doi: 10.1021/acsmedchemlett.9b00239. eCollection 2019 Sep 12. ACS Med Chem Lett. 2019. PMID: 31531193 Free PMC article.

6

Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.

Nevagi RJ, Dai W, Khalil ZG, Hussein WM, Capon RJ, Skwarczynski M, Toth I. Nevagi RJ, et al. Eur J Med Chem. 2019 Oct 1;179:100-108. doi: 10.1016/j.ejmech.2019.06.047. Epub 2019 Jun 18. Eur J Med Chem. 2019. PMID: 31247372

7

Self-assembly of trimethyl chitosan and poly(anionic amino acid)-peptide antigen conjugate to produce a potent self-adjuvanting nanovaccine delivery system.

Nevagi RJ, Dai W, Khalil ZG, Hussein WM, Capon RJ, Skwarczynski M, Toth I. Nevagi RJ, et al. Bioorg Med Chem. 2019 Jul 15;27(14):3082-3088. doi: 10.1016/j.bmc.2019.05.033. Epub 2019 May 22. Bioorg Med Chem. 2019. PMID: 31176567

8

Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.

Nevagi RJ, Khalil ZG, Hussein WM, Powell J, Batzloff MR, Capon RJ, Good MF, Skwarczynski M, Toth I. Nevagi RJ, et al. Acta Biomater. 2018 Oct 15;80:278-287. doi: 10.1016/j.actbio.2018.09.037. Epub 2018 Sep 25. Acta Biomater. 2018. PMID: 30266637

9

Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.

Wan Y, Dai W, Nevagi RJ, Toth I, Moyle PM. Wan Y, et al. Among authors: nevagi rj. Acta Biomater. 2017 Sep 1;59:257-268. doi: 10.1016/j.actbio.2017.06.032. Epub 2017 Jun 24. Acta Biomater. 2017. PMID: 28655658

10

Biological and medicinal significance of benzofuran.

Nevagi RJ, Dighe SN, Dighe SN. Nevagi RJ, et al. Eur J Med Chem. 2015 Jun 5;97:561-81. doi: 10.1016/j.ejmech.2014.10.085. Epub 2014 Nov 7. Eur J Med Chem. 2015. PMID: 26015069 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page